Skip to main content

Home/ health information/ Group items tagged Kamila-Hawthorne

Rss Feed Group items tagged

pharmacybiz

Kamila Hawthorne Receives GG2 Woman of the Year Award - 0 views

  •  
    Kamila Hawthorne, the chair of the Royal College of General Practitioners (RCGP) Council, was honoured with the GG2 Woman of the Year Award at the annual GG2 Leadership and Diversity Awards, held at the Park Plaza Hotel on Tuesday, 5 March. Hawthorne has been a practitioner and a mentor to young GPs for almost 35 years, and has led pioneering research projects focusing on health inequalities, diabetes and heart disease. She has been recognised twice as GP of the Year for her work with minority ethnic communities. Professor Kiran Patel, Group Chief Medical Officer at University Hospitals Birmingham NHS Foundation Trust, was named the GG2 Man of the Year Award. Apart from being a sought-after cardiologist and consultant, Patel also possesses a wealth of experience in managerial roles. He has done a lot of work in addressing health inequalities, and notably, in 2020, he prescribed the very first COVID-19 vaccine.
pharmacybiz

GPs in Deprived Areas Face Mounting Workload: 2,450 Patients Per Doctor - RCGP Study - 0 views

  •  
    The Royal College of GPs (RCGP) has called on the government to increase investment in general practice, stating that they are now "seriously struggling" due to years of underfunding and neglect. As evidence of the mounting workload pressures faced by GPs, new research published by the RCGP has revealed that GPs are now responsible for an average of 2,300 patients each. Concerningly, the ratio has become even worse in areas of higher deprivation, where the need is greatest. The RCGP research found that over the past six years, the average number of patients per GP in areas with the highest level of income deprivation has risen by 260, marking a 12 per cent increase-nearly double the rate observed in the least deprived areas. In these areas, one GP is responsible for 2,450 patients, which is over 300 more patients than their counterparts in the least deprived regions. Addressing the RCGP's annual conference 2024 in Liverpool on Thursday, College Chair Professor Kamila Hawthorne said: "When I became a GP, it was normal to have a list size between 1,600-1,800 patients. The role was busy and challenging, but it was manageable. Our latest figures reveal that the average is now 2,300.
pharmacybiz

RCGP Urges Protection for GP Practices Amid National Insurance Hike - 0 views

  •  
    The Royal College of General Practitioners (RCGP) has raised 'serious concerns' about the impact of the increase in National Insurance on GP practices, and is calling for adequate funding to cover these additional costs. In the 2024 Budget of the new Labour government, the rate of employer National Insurance Contributions (NICs) was raised by 1.2 percentage points to 15%, effective from 6 April 2025. The per-employee threshold at which employers start paying NICs was also reduced from £9,100 per year to £5,000 per year. RCGP Chair Professor Kamila Hawthorne has warned that this extra financial burden could lead to the closure of some GP practices. "We have very serious concerns about the impact of the increase in National Insurance employer contributions on GP practices right across the country, many of whom are already struggling to keep their doors open and make ends meet due to historic chronic underfunding.
pharmacybiz

Weight Loss Drugs: Risks, Benefits, and NHS Impact | RCGP Insights 2024 - 0 views

  •  
    Professor Kamila Hawthorne, chair of the Royal College of GPs, has cautioned that while weight loss drugs hold significant potential to enhance many patients' lives, they are not without risks. She also expressed concern that expanding the roll out of tirzepatide at the scale proposed by the National Institute for Health and Care Excellence (NICE) would have "significant practical and resource implications for the NHS and primary care." The final draft guidance from NICE, published on 5 December, suggests that around 220,000 people living with obesity will be offered the weekly injection, along with a reduced-calorie diet and increased physical activity, over the next three years. Marketed under the brand name Mounjaro by Eli Lilly, tirzepatide is recommended for people with a body mass index (BMI) of more than 35 and at least one weight-related illness. Accepting the request from NHS England to roll out the medication over 12 years, the NICE guidance proposes to prioritise those with the highest clinical need.
1 - 4 of 4
Showing 20 items per page